4-diacetylaminoazotoluene,
Dermagan,
diacetazotol,
pellidol,
Diacetazotol,
Pellidol,
Diacetotoluide,
Diacetylaminoazotoluene,
Dermagan,
Epithelone,
Pellidole,
Diamazo,
Dimazon,
83-63-6,
Periphermin,
Dermagen,
Epidermol,
Granulin,
N,N-Diacetyl-o-aminoazotoluene,
4-o-Tolylazo-o-diacetotoluide,
4''-(ortho-Tolylazo)-ortho-diacetoluidide,
NSC 6509,
4'-(o-Tolylazo)-o-diacetotoluidide,
N,N-Diacetyl-o-tolylazo-o-toluidine,
UNII-U1925T7L3Z,
EINECS 201-490-0,
N-(4-o-Tolylazo-o-tolyl)diacetamide,
Acetamide, N-acetyl-N-[2-methyl-4-[(2-methylphenyl)azo]phenyl]-,
BRN 0686326,
o-Diacetotoluidide, 4''-(o-tolylazo)-,
N-Acetyl-N-(2-methyl-4-((2-methylphenyl)azo)phenyl)acetamide,
U1925T7L3Z,
4''-(o-Tolylazo)-o-diacetotoluide,
4''-(o-Tolylazo)-o-diacetotoluidide,
Acetamide, N-acetyl-N-(2-methyl-4-((2-methylphenyl)azo)phenyl)-,
azodolen,
WLN: 1VNV1&R B DNUNR B,
Periphermine,
N-Acetyl-N-[2-methyl-4-[(2-methylphenyl)azo]phenyl]acetamide,
N-acetyl-N-[2-methyl-4-[(2-methylphenyl)diazenyl]phenyl]acetamide,
N-acetyl-N-{2-methyl-4-[(2-methylphenyl)diazenyl]phenyl}acetamide,
Orange G (Salt/Mix),
AC1Q5HVK,
AC1Q1K6R,
3-16-00-00387 (Beilstein Handbook Reference),
Acid orange 10 (Salt/Mix),
C.I. Orange G (Salt/Mix),
AC1L1N84,
Acidal Fast Orange (Salt/Mix),
SCHEMBL12848332,
SCHEMBL14582013,
CHEBI:81046,
NSC6509,
NSC7221,
YIEDSISPYKQADU-FMQUCBEESA-N,
HY-B2187,
N,N-Diacetyl-o-tolyazo-o-toluidine,
NSC-6509,
NSC-7221,
MFCD00026179,
SBB057415,
ZINC16362544,
AKOS024257947,
AKOS024332194,
ZINC100069197,
ZINC254869689,
4-Diacetamido-2',3-dimethylazobenzene,
API0012943,
CS-7499,
LS-7973,
MCULE-9421076450,
CJ-15505,
2,3'-Dimethyl-4'-(diacetylamino)azobenzene,
D0063,
ST50545349,
C17380,
o-Diacetotoluidide, 4''-(o-tolylazo)- (8CI),
N-Acetyl-N-(2-methyl-4-[(2-methylphenyl)diazenyl]phenyl)acetamide #,
N-acetyl-N-{2-methyl-4-[2-(2-methylphenyl)diazen-1-yl]phenyl}acetamide,
crotamiton,
Diazol,
Acidal Fast Orange,
CID6751,
C18H19N3O2,
N-(4-o-tolylazo-o-tolyl)diacetamid,
AR-1H7670,
C18-H19-N3-O2,
32914-95-7,